DR. HUASHENG LU, MD, PHD
Osteopathic Medicine at Medical Center Dr, Rockville, MD
License number
Maryland D0074493
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
9901 Medical Center Dr, Rockville, MD 20850
18806 Broken Oak Rd, Boyds, MD 20841
18806 Broken Oak Rd, Boyds, MD 20841
Phone
(240) 826-5710
(301) 972-1045
(301) 972-1045
Personal information
See more information about HUASHENG LU at radaris.comName
Address
Phone
18801 Lake Placid Ln, Germantown, MD 20874
Gaithersburg, MD
1001 Rockville Pike, Rockville, MD 20852
18806 Broken Oak Rd, Boyds, MD 20841
612 Walker Ave, Baltimore, MD 21212
Organization information
See more information about HUASHENG LU at bizstanding.comInpatient Specialtists - Huasheng Lu MD
9901 Medical Ctr Dr, Rockville, MD 20850
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(301) 279-6000 (Phone)
Professional information
See more information about HUASHENG LU at trustoria.com
Dr. Huasheng Lu, Rockville MD - MD (Doctor of Medicine)
Dr. Huasheng Lu, Rockville MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
9901 Medical Center Dr, Rockville 20850
Certifications:
Internal Medicine, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Huasheng Lu, Rockville MD
Huasheng Lu, Rockville MD
Specialties:
Internist
Address:
9901 Medical Center Dr, Rockville, MD 20850
Activation Of Hypoxia-Inducible Gene Expression
Activation Of Hypoxia-Inducible Gene Expression
US Patent:
2007017, Jul 26, 2007
Filed:
Nov 8, 2004
Appl. No.:
10/578438
Inventors:
Ajay Verma - Harleysville PA, US
Huasheng Lu - Boyds MD, US
Robert Forbes - Princeton NJ, US
Clifton Dalgard - San Francisco CA, US
Ahmed Mohyeldin - Washington DC, US
Ronald Zenk - Eden Prairie MN, US
Huasheng Lu - Boyds MD, US
Robert Forbes - Princeton NJ, US
Clifton Dalgard - San Francisco CA, US
Ahmed Mohyeldin - Washington DC, US
Ronald Zenk - Eden Prairie MN, US
International Classification:
A61K 31/19, A61K 31/21, C12N 15/01
US Classification:
514506000, 435441000, 514557000
Abstract:
The present invention relates to the elucidation of specific molecular features of endogenous 2-oxoacid molecules and their derivatives for activating hypoxia-inducible gene expression by inactivating hypoxia-inducible factor hydroxylating enzymes. This invention identifies agents that can be used to induce tissue vascularization, treat anemias, induce tolearance to stroke and heart attacks, improve tissue healing and improve organ transplantation.
Methods For Lowering Hif-1 Mediated Gene Expression
Methods For Lowering Hif-1 Mediated Gene Expression
US Patent:
2008004, Feb 21, 2008
Filed:
Oct 25, 2005
Appl. No.:
11/666229
Inventors:
Ajay Verma - Harleysville PA, US
Huasheng Lu - Boyds MD, US
Huasheng Lu - Boyds MD, US
International Classification:
A61K 31/195, A61K 31/34, A61K 31/415, A61K 38/00, A61P 43/00
US Classification:
514018000, 514399000, 514474000, 514562000
Abstract:
The present invention relates to the elucidation of specific molecular features of endogenous amino acids and their derivatives for inhibiting hypoxia-inducible gene expression by preventing inactivation of hypoxia-inducible factor hydroxylating enzymes. This invention encompasses agents that can be used to reduce tissue vascularization, cancer cell survival, and to treat obesity.